Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Review(3)
Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in latin America
ReviewAbstract: Pharmacogenetics and Pharmacogenomics areas are currently emerging fields focused to manage pharmacoPalabras claves:adverse drug reactions, Biomarkers, Clinical recommendations, Clinical relevance, PharmacogenomicsAutores:Agúndez J.A.G., Andrés López-Cortés, Cáceres D.D., Castañeda-Hernández G., Cayún J.P., Chiurillo M.A., De Guerra D.C., Encina G., Enrique Terán, Eslava-Schmalbach J., Estévez-Carrizo F.E., García-Martin E., Herrera L., Isaza C.A., Lares-Assef I., Laróvere L., Lavanderos M.A., López M.L., Magno L.A., Morales J.E., Quiñones L.A., Redal M.A., Roco A.M., Rodeiro I., Soria N.W.Fuentes:googlescopusPharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response
ReviewAbstract: Carbamazepine (CBZ) is a first-line widely used anticonvulsant. It has a narrow therapeutic index anPalabras claves:adverse drug reaction, carbamazepine, Drug resistance, genetic polymorphism, human leukocyte antigen (HLA), pharmacogeneticsAutores:Adrián LLerena, Cook H.J., Galindo I.F., López M.L., MELANIE BRIGETTE ARROYO LOPEZ, Monroy-Jaramillo N., Vázquez A.O.Fuentes:googlescopusPharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine
ReviewAbstract: Patients treated with antiepileptic drugs can exhibit large interindividual variability in clinicalPalabras claves:antiepileptic drug, Cytochrome p450, lamotrigine, pharmacogenetics, Phenytoin, UDP-glucuronosyltransferase (UGT)Autores:Adrián LLerena, Dorado P., ElisaAlonso M., Jung-Cook H., López M.L., Machín E., MELANIE BRIGETTE ARROYO LOPEZ, Monroy-Jaramillo N., Penãs-Lledó E.M.Fuentes:googlescopus